Association of different fractionation schedules for prophylactic cranial irradiation with toxicity and brain metastases-free survival in locally advanced non-small cell lung cancer: a pooled analysis of individual patient data from three randomized trials.

[1]  H. Groen,et al.  Individual patient data meta-analysis of prophylactic cranial irradiation in locally advanced non-small cell lung cancer. , 2021, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[2]  H. Choy,et al.  Prophylactic Cranial Irradiation vs Observation in Patients With Locally Advanced Non-Small Cell Lung Cancer: A Long-term Update of the NRG Oncology/RTOG 0214 Phase 3 Randomized Clinical Trial. , 2019, JAMA oncology.

[3]  H. Groen,et al.  Prophylactic Cranial Irradiation Versus Observation in Radically Treated Stage III Non-Small-Cell Lung Cancer: A Randomized Phase III NVALT-11/DLCRG-02 Study. , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  Andre Dekker,et al.  Stereotactic Radiosurgery in the Management of Patients With Brain Metastases of Non-Small Cell Lung Cancer: Indications, Decision Tools and Future Directions , 2018, Front. Oncol..

[5]  Q. Fang,et al.  Randomized phase III trial of prophylactic cranial irradiation versus observation in patients with fully resected stage IIIA-N2 nonsmall-cell lung cancer and high risk of cerebral metastases after adjuvant chemotherapy. , 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

[6]  D. Ball,et al.  Treatment of Brain Metastases in Lung Cancer: Strategies to Avoid/Reduce Late Complications of Whole Brain Radiation Therapy , 2013, Current Treatment Options in Oncology.

[7]  H. Choy,et al.  Decline in tested and self-reported cognitive functioning after prophylactic cranial irradiation for lung cancer: pooled secondary analysis of Radiation Therapy Oncology Group randomized trials 0212 and 0214. , 2013, International journal of radiation oncology, biology, physics.

[8]  H. Choy,et al.  Primary analysis of a phase II randomized trial Radiation Therapy Oncology Group (RTOG) 0212: impact of different total doses and schedules of prophylactic cranial irradiation on chronic neurotoxicity and quality of life for patients with limited-disease small-cell lung cancer. , 2011, International journal of radiation oncology, biology, physics.

[9]  Mike Partridge,et al.  Dose escalation for non-small cell lung cancer: analysis and modelling of published literature. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[10]  H. Choy,et al.  Phase III comparison of prophylactic cranial irradiation versus observation in patients with locally advanced non-small-cell lung cancer: primary analysis of radiation therapy oncology group study RTOG 0214. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  H. Choy,et al.  Phase III trial of prophylactic cranial irradiation compared with observation in patients with locally advanced non-small-cell lung cancer: neurocognitive and quality-of-life analysis. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  R. Arriagada,et al.  Standard-dose versus higher-dose prophylactic cranial irradiation (PCI) in patients with limited-stage small-cell lung cancer in complete remission after chemotherapy and thoracic radiotherapy (PCI 99-01, EORTC 22003-08004, RTOG 0212, and IFCT 99-01): a randomised clinical trial. , 2009, The Lancet. Oncology.

[13]  V. Budach,et al.  Prophylactic cranial irradiation in operable stage IIIA non small-cell lung cancer treated with neoadjuvant chemoradiotherapy: results from a German multicenter randomized trial. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  S. Thompson,et al.  Quantifying heterogeneity in a meta‐analysis , 2002, Statistics in medicine.

[15]  J. M. Taylor,et al.  Dose-response relationship for radiation therapy of subclinical disease. , 1995, International journal of radiation oncology, biology, physics.

[16]  J. Cooper,et al.  Prophylactic cranial irradiation for lung cancer patients at high risk for development of cerebral metastasis: results of a prospective randomized trial conducted by the Radiation Therapy Oncology Group. , 1991, International journal of radiation oncology, biology, physics.

[17]  D. Booser,et al.  Role of elective brain irradiation during combined chemoradiotherapy for limited disease non-small cell lung cancer , 1984, Journal of Neuro-Oncology.

[18]  Z. Petrovich,et al.  Cranial irradiation in cancer of the lung of all cell types. , 1981, JAMA.

[19]  J. Crowley,et al.  Chest irradiation (RT) vs. chest RT + chemotherapy ± prophylactic brain RT in localized non small cell lung cancer: A southwest oncology group randomized study , 1990 .